Literature DB >> 10412035

Three-dimensional model of the ligand binding domain of the nuclear receptor for 1alpha,25-dihydroxy-vitamin D(3).

A W Norman1, D Adams, E D Collins, W H Okamura, R J Fletterick.   

Abstract

A three-dimensional model for residues 142-427 of the ligand binding domain (LBD) of the human nuclear receptor for 1alpha, 25-dihydroxy-vitamin D(3) [VDR] has been generated based on the X-ray crystallographic atomic coordinates of the LBD of the rat alpha1 thyroid receptor (TR). The VDR LBD model is an elongated globular shape comprised of an antiparallel alpha-helical triple sandwich topology, made up of 12 alpha-helical elements linked by short loop structures; collectively these structural features are similar to the characteristic secondary and tertiary structures for six nuclear receptors with known X-ray structures. The model has been used to describe the interaction of the conformationally flexible natural hormone, 1alpha,25-dihydroxy-vitamin D(3) [1alpha, 25(OH)(2)D(3)], and a number of related analogs with the VDR LBD. The optimal orientation of the 1alpha,25(OH)(2)D(3) in the LBD is with its A-ring directed towards the interior and its flexible side chain pointing towards and interacting with helix-12, site of the activation function-2 domain (AF-2) of the VDR. Mapping of four natural and one experimental point mutations of the VDR LBD, which result in ligand-related receptor dysfunction, indicates the close proximity of these amino acids to the bound ligand. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10412035

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain.

Authors:  K Yamamoto; H Masuno; M Choi; K Nakashima; T Taga; H Ooizumi; K Umesono; W Sicinska; J VanHooke; H F DeLuca; S Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis.

Authors:  K Uenishi; M Tokiwa; S Kato; M Shiraki
Journal:  Osteoporos Int       Date:  2017-12-23       Impact factor: 4.507

Review 3.  Adjudication of the alleged role of vitamin d in the antimicrobial pathway.

Authors:  Gerald M Higa; Jason Hicks; Christopher Isabella
Journal:  Scientifica (Cairo)       Date:  2012-06-25

Review 4.  Relationship between Structure and Conformational Change of the Vitamin D Receptor Ligand Binding Domain in 1α,25-Dihydroxyvitamin D3 Signaling.

Authors:  Lin-Yan Wan; Yan-Qiong Zhang; Meng-Di Chen; You-Qin Du; Chang-Bai Liu; Jiang-Feng Wu
Journal:  Molecules       Date:  2015-11-18       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.